BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 32368615)

  • 1. Ectopic Expression of miR-532-3p Suppresses Bone Metastasis of Prostate Cancer Cells via Inactivating NF-κB Signaling.
    Wa Q; Zou C; Lin Z; Huang S; Peng X; Yang C; Ren D; Xu D; Guo Y; Liao Z; Wang B; Hu H; Huang S; He P
    Mol Ther Oncolytics; 2020 Jun; 17():267-277. PubMed ID: 32368615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Downregulation of miR-141-3p promotes bone metastasis via activating NF-κB signaling in prostate cancer.
    Huang S; Wa Q; Pan J; Peng X; Ren D; Huang Y; Chen X; Tang Y
    J Exp Clin Cancer Res; 2017 Dec; 36(1):173. PubMed ID: 29202848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oncogenic miR-210-3p promotes prostate cancer cell EMT and bone metastasis via NF-κB signaling pathway.
    Ren D; Yang Q; Dai Y; Guo W; Du H; Song L; Peng X
    Mol Cancer; 2017 Jul; 16(1):117. PubMed ID: 28693582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-204-5p Represses Bone Metastasis via Inactivating NF-κB Signaling in Prostate Cancer.
    Wa Q; Huang S; Pan J; Tang Y; He S; Fu X; Peng X; Chen X; Yang C; Ren D; Huang Y; Liao Z; Huang S; Zou C
    Mol Ther Nucleic Acids; 2019 Dec; 18():567-579. PubMed ID: 31678733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR-582-3p and miR-582-5p Suppress Prostate Cancer Metastasis to Bone by Repressing TGF-β Signaling.
    Huang S; Zou C; Tang Y; Wa Q; Peng X; Chen X; Yang C; Ren D; Huang Y; Liao Z; Huang S; Zou X; Pan J
    Mol Ther Nucleic Acids; 2019 Jun; 16():91-104. PubMed ID: 30852380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Downregulation of miR-133a-3p promotes prostate cancer bone metastasis via activating PI3K/AKT signaling.
    Tang Y; Pan J; Huang S; Peng X; Zou X; Luo Y; Ren D; Zhang X; Li R; He P; Wa Q
    J Exp Clin Cancer Res; 2018 Jul; 37(1):160. PubMed ID: 30021600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased miR-218-5p Levels as a Serum Biomarker in Bone Metastasis of Prostate Cancer.
    Peng P; Chen T; Wang Q; Zhang Y; Zheng F; Huang S; Tang Y; Yang C; Ding W; Ren D; Huang Z; Guo Y
    Oncol Res Treat; 2019; 42(4):165-185. PubMed ID: 30870834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcriptional downregulation of miR-133b by REST promotes prostate cancer metastasis to bone via activating TGF-β signaling.
    Huang S; Wa Q; Pan J; Peng X; Ren D; Li Q; Dai Y; Yang Q; Huang Y; Zhang X; Zhou W; Yuan D; Cao J; Li Y; He P; Tang Y
    Cell Death Dis; 2018 Jul; 9(7):779. PubMed ID: 30006541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-23b-3p promotes pancreatic cancer cell tumorigenesis and metastasis via the JAK/PI3K and Akt/NF-κB signaling pathways.
    Zhang Y; Chen D; Zhang G; Wu X; Zhou L; Lin Y; Ding J; An F; Zhan Q
    Oncol Lett; 2020 Nov; 20(5):160. PubMed ID: 32934728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered expression of microRNA-92b-3p predicts survival outcomes of patients with prostate cancer and functions as an oncogene in tumor progression.
    Wang G; Cheng B; Jia R; Tan B; Liu W
    Oncol Lett; 2021 Jan; 21(1):4. PubMed ID: 33240410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-331-3p and Aurora Kinase inhibitor II co-treatment suppresses prostate cancer tumorigenesis and progression.
    Epis MR; Giles KM; Beveridge DJ; Richardson KL; Candy PA; Stuart LM; Bentel J; Cohen RJ; Leedman PJ
    Oncotarget; 2017 Aug; 8(33):55116-55134. PubMed ID: 28903407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of miR-516a-3p mediates upregulation of ABCC5 in prostate cancer and drives its progression.
    Zhang H; Lian Z; Sun G; Liu R; Xu Y
    Onco Targets Ther; 2018; 11():3853-3867. PubMed ID: 30013366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The TGF-β signalling negative regulator PICK1 represses prostate cancer metastasis to bone.
    Dai Y; Ren D; Yang Q; Cui Y; Guo W; Lai Y; Du H; Lin C; Li J; Song L; Peng X
    Br J Cancer; 2017 Aug; 117(5):685-694. PubMed ID: 28697177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EBV-miR-BART8-3p induces epithelial-mesenchymal transition and promotes metastasis of nasopharyngeal carcinoma cells through activating NF-κB and Erk1/2 pathways.
    Lin C; Zong J; Lin W; Wang M; Xu Y; Zhou R; Lin S; Guo Q; Chen H; Ye Y; Zhang B; Pan J
    J Exp Clin Cancer Res; 2018 Nov; 37(1):283. PubMed ID: 30477559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exosomal miR-141-3p regulates osteoblast activity to promote the osteoblastic metastasis of prostate cancer.
    Ye Y; Li SL; Ma YY; Diao YJ; Yang L; Su MQ; Li Z; Ji Y; Wang J; Lei L; Fan WX; Li LX; Xu Y; Hao XK
    Oncotarget; 2017 Nov; 8(55):94834-94849. PubMed ID: 29212270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-15a-3p Suppresses Prostate Cancer Cell Proliferation and Invasion by Targeting SLC39A7 Via Downregulating Wnt/β-Catenin Signaling Pathway.
    Cui Y; Yang Y; Ren L; Yang J; Wang B; Xing T; Chen H; Chen M
    Cancer Biother Radiopharm; 2019 Sep; 34(7):472-479. PubMed ID: 31135177
    [No Abstract]   [Full Text] [Related]  

  • 17. Transcriptional downregulation of miR-127-3p by CTCF promotes prostate cancer bone metastasis by targeting PSMB5.
    Fan J; Du W; Zhang H; Wang Y; Li K; Meng Y; Wang J
    FEBS Lett; 2020 Feb; 594(3):466-476. PubMed ID: 31562641
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-17-3p promotes keratinocyte cells growth and metastasis via targeting MYOT and regulating Notch1/NF-κB pathways.
    Yan H; Song K; Zhang G
    Pharmazie; 2017 Sep; 72(9):543-549. PubMed ID: 29441982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MiR-199a-3p suppresses proliferation and invasion of prostate cancer cells by targeting Smad1.
    Qu F; Zheng J; Gan W; Lian H; He H; Li W; Yuan T; Yang Y; Li X; Ji C; Yan X; Xu L; Guo H
    Oncotarget; 2017 Aug; 8(32):52465-52473. PubMed ID: 28881744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-323-3p inhibits cell invasion and metastasis in pancreatic ductal adenocarcinoma via direct suppression of SMAD2 and SMAD3.
    Wang C; Liu P; Wu H; Cui P; Li Y; Liu Y; Liu Z; Gou S
    Oncotarget; 2016 Mar; 7(12):14912-24. PubMed ID: 26908446
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.